← Back to Clinical Trials
Recruiting NCT06873880

Integrating BIA and eGFR for Nutritional Status in Hemodialysis Patients

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Chronic Kidney Disease Requiring Chronic Dialysis
Sponsor University of Tartu
Study Type OBSERVATIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-02-10
Completion 2025-05-31

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study looks at how measurements of body composition from Bioelectrical Impedance Analysis (BIA) and estimates of kidney function (eGFR) can be applied together to better assess the health of people on hemodialysis. Many dialysis patients struggle with malnutrition, muscle loss, and fluid imbalances, but current assessment methods rely on unsophisticated tests and observations. By combining BIA and eGFR, this study aims to provide a more accurate and non-invasive way to monitor nutrition and overall health, which could lead to better treatment decisions and improved patient outcomes.

Eligibility Criteria

Inclusion Criteria: Chronic kidney disease Hemodialysis for at least 6 months Exclusion Criteria: Pregnancy Lactation Major second pathology Pacemaker Recent surgery

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE CHRONIC KIDNEY DISEASE REQUIRING CHRONIC DIALYSIS TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}